Overview

fluoropyrimidine


'fluoropyrimidine' can also refer to...

fluoropyrimidine

fluoropyrimidine n.

P-0255CARDIAC TOXICITY WITH FLUOROPYRIMIDINES IN COLORECTAL CANCER

Retrospective Analysis of S-1 Monotherapy in Patients with Metastatic Colorectal Cancer After Failure to Fluoropyrimidine and Irinotecan or to Fluoropyrimidine, Irinotecan and Oxaliplatin

P-0086INTRAVENOUS VERSUS ORAL FLUOROPYRIMIDINE: POST GASTRECTOMY CHEMORADIATION WITH JEJUNAL INTERPOSITION RECONSTRUCTION

Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil

A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy†

P-0254TOLERANCE OF RALTITREXED WHEN REPLACING A FLUOROPYRIMIDINE IN COLORECTAL CANCER

Role of interferon as a modulator of fluoropyrimidines: Reply to a recent editorial

Phase II Study of Oxaliplatin in Japanese Patients with Metastatic Colorectal Cancer Refractory to Fluoropyrimidines

Case Report: Hand–Foot Syndrome Induced by the Oral Fluoropyrimidine S-1

Biochemical Modulation of Fluoropyrimidines: Is There an Optimal (6R, S)Leucovorin Dose and Schedule?

A Randomized Phase III trial of Post-operative Adjuvant Oral Fluoropyrimidine versus Sequential Paclitaxel/Oral Fluoropyrimidine; and UFT versus S1 for T3/T4 Gastric Carcinoma: The Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial

IS4–4HOW TO USE ORAL FLUOROPYRIMIDINE IN TRIPLET OR DOUBLET THERAPY AS THE EUROPEAN STANDARD

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study

Gefitinib and irinotecan in patients with fluoropyrimidine-refractory, irinotecan-naive advanced colorectal cancer: a phase I–II study

Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer

Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines†

P-204Toxicological and biochemical assessment of specific COX-2 inhibitor as adjuvant in fluoropyrimidine therapy in chemically induced colon cancer

 

More Like This

Show all results sharing this subject:

  • Medicine and Health

GO

Show Summary Details

Quick Reference

n. any one of a class of antimetabolite drugs used in the treatment of gastrointestinal malignancies and breast cancer. They include fluorouracil and the orally administered drugs capecitabine and tegafur/uracil (Uftoral).

Subjects: Medicine and Health.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.